Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis

doi:10.3748/wjg.v12.i4.520

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3499)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

355

HTML

2745

Figures (1-1)

191

Tables (1-1)

208

Sum=3499

Jan 28, 2006 (publication date) through Jan 4, 2025

Times Cited of This Article

Times Cited (26)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Jan 28, 2006; 12(4): 520-525
Published online Jan 28, 2006. doi: 10.3748/wjg.v12.i4.520

Full Size Figure Download Figure

Figure 1 An outline of GMCAP procedures using the Adacolumn. Blood is drawn into the column from the antecubital vein of one hand, and returned to the patient via antecubital vein of the contralateral hand. GMCAP, granulocyte, and monocyte/macrophage adsorptive apheresis.

Citation: Yamamoto T, Umegae S, Matsumoto K. Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis. World J Gastroenterol 2006; 12(4): 520-525
URL: https://www.wjgnet.com/1007-9327/full/v12/i4/520.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i4.520